You don't make much net when you sell. You REALLY make money when you buy. Today may be a great money making opportunity.
That's quite literally the opposite of the truth. You MAKE money when you sell for a profit. You don't make anything with the original buy as it can go either way. The 3rd sentence I have no opinion on as I am not familiar with this company. It does look to have a nice little upward trend going, but I'd be looking to buy more around the white line below which I would call upward support.
look at the chart T0rmented posted and the one below.... SGYP went down ever since...but is it ready to climb back up? look today volume (13 millions more then the average!!!) few weeks back news for info... DD Jun-03-17 11:13AM Here's the Volatile Biotech Stock One Analyst Thinks Could Boom 175% TheStreet.com Jun-02-17 01:03PM Why Synergy Pharmaceuticals Shares Are Popping 16.7% Today Motley Fool +10.19% May-30-17 08:30AM Synergy Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference Business Wire May-29-17 01:32PM With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory? Motley Fool May-17-17 10:01AM Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks -6.33% May-15-17 04:59PM What Do the Ardelyx Numbers Mean for the Company? GuruFocus.com -8.31% 08:00AM Synergy Pharmaceuticals and Durect Corporation Both Sail Higher on Trader Optimism Accesswire May-10-17 06:44PM Synergy Pharma reports 1Q loss Associated Press 04:54PM Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update Business Wire May-09-17 11:46AM Synergy Scores Again: Trulance Product Meets Phase 3 Endpoints In Second Indication Benzinga 11:45AM Synergy Pharmaceuticals to Present Positive TRULANCE (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire May-07-17 10:30AM Synergy Presents New Insights at Digestive Disease Week (DDW) Examining Patient and Physician Perceptions and Experiences with Chronic Idiopathic Constipation (CIC) Business Wire
Synergy Pharmaceuticals Secures $300 Million Debt Financing https://finance.yahoo.com/news/synergy-pharmaceuticals-secures-300-million-123000864.html
